PTK787/ZK222584 With Bevacizumab in Patients With Refractory and/or Advanced Malignancies
Clinical trial NCT00611793 · COMPLETED
Trial details
- NCT number
- NCT00611793
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-01
- Primary completion
- 2008-01-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.